Bausch Health Companies Inc. (BHC)
NYSE: BHC · Real-Time Price · USD
6.46
+0.05 (0.78%)
At close: Jun 27, 2025, 4:00 PM
6.50
+0.04 (0.62%)
After-hours: Jun 27, 2025, 7:21 PM EDT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2014 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2014 - 2020 |
Other Revenue seg1 | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Bausch + Lomb | 4.83B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Bausch + Lomb Growth | 11.94% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Salix | 2.38B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Salix Growth | 5.46% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Diversified Products | 953.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Diversified Products Growth | 0.53% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Ortho Dermatologies | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Ortho Dermatologies Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
International Rx | 1.11B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
International Rx Growth | 1.74% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Solta Medical | 465.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Solta Medical Growth | 28.45% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2014 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2014 - 2020 |
Bausch + Lomb Segment Profit | 1.05B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Bausch + Lomb Segment Profit Growth | 3.46% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other EBIT seg1 | -2.10B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other EBIT seg1 Growth | 5.16% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Salix Segment Profit | 1.64B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Salix Segment Profit Growth | 5.18% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Diversified Products Segment Profit | 639.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Diversified Products Segment Profit Growth | 7.76% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Ortho Dermatologies Segment Profit | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Ortho Dermatologies Segment Profit Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
International Rx Segment Profit | 374.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
International Rx Segment Profit Growth | 8.41% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Solta Medical Segment Profit | 226.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Solta Medical Segment Profit Growth | 36.97% |
Log In |
Log In |
Log In |
Log In | Upgrade
|